no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a Regimen
|
de Gramont, A |
|
1998 |
34 |
5 |
p. 619-626 8 p. |
article |
2 |
bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma
|
Fontanini, G. |
|
1998 |
34 |
5 |
p. 718-723 6 p. |
article |
3 |
Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial
|
Glimelius, B |
|
1998 |
34 |
5 |
p. 674-678 5 p. |
article |
4 |
Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinoma
|
Gasperi-Campani, A |
|
1998 |
34 |
5 |
p. 724-730 7 p. |
article |
5 |
Editorial
|
|
|
1998 |
34 |
5 |
p. 603-605 3 p. |
article |
6 |
Editorial
|
|
|
1998 |
34 |
5 |
p. 606-608 3 p. |
article |
7 |
Editorial
|
|
|
1998 |
34 |
5 |
p. 757-758 2 p. |
article |
8 |
Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma
|
Mandai, M |
|
1998 |
34 |
5 |
p. 745-749 5 p. |
article |
9 |
Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy
|
Sinn, H.P. |
|
1998 |
34 |
5 |
p. 646-653 8 p. |
article |
10 |
Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095
|
Miyazaki, M |
|
1998 |
34 |
5 |
p. 710-717 8 p. |
article |
11 |
Is determination of angiogenic activity in human tumours clinically useful?
|
Walker, R.A |
|
1998 |
34 |
5 |
p. 614-615 2 p. |
article |
12 |
Is determination of angiogenic activity in human tumours clinically useful?
|
Gasparini, G |
|
1998 |
34 |
5 |
p. 615-618 4 p. |
article |
13 |
Is determination of angiogenic activity in human tumours clinically useful?
|
Ellis, L.M |
|
1998 |
34 |
5 |
p. 609-613 5 p. |
article |
14 |
Isolated leptomeningeal metastasis from ovarian carcinoma: an unusual event
|
Delord, J.P |
|
1998 |
34 |
5 |
p. 758-759 2 p. |
article |
15 |
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study
|
Schuler, M |
|
1998 |
34 |
5 |
p. 754-756 3 p. |
article |
16 |
Multiple primary neoplasms in childhood: data from the German children’s cancer registry
|
Westermeier, T |
|
1998 |
34 |
5 |
p. 687-693 7 p. |
article |
17 |
Oncogenic ras modulates epidermal growth factor responsiveness in endometrial carcinomas
|
Kato, K |
|
1998 |
34 |
5 |
p. 737-744 8 p. |
article |
18 |
One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial
|
Hainsworth, J.D. |
|
1998 |
34 |
5 |
p. 654-658 5 p. |
article |
19 |
Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation Factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR
|
Bertram, J |
|
1998 |
34 |
5 |
p. 731-736 6 p. |
article |
20 |
Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas
|
Lokich, J |
|
1998 |
34 |
5 |
p. 664-667 4 p. |
article |
21 |
Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer
|
Lokich, J |
|
1998 |
34 |
5 |
p. 659-663 5 p. |
article |
22 |
Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin’s lymphomas
|
Çelik, I |
|
1998 |
34 |
5 |
p. 759-760 2 p. |
article |
23 |
Predictive factors and opioid responsiveness in cancer pain 1 This paper was presented in part as a lecture at the 20th Annual Meeting of the Scandinavian Association for the Study of Pain, Aarhus, 17–20 April 1997. 1
|
Mercadante, S |
|
1998 |
34 |
5 |
p. 627-631 5 p. |
article |
24 |
Pre-operative chemotherapy and radiotherapy in breast cancer
|
Colleoni, M |
|
1998 |
34 |
5 |
p. 641-645 5 p. |
article |
25 |
Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction
|
Stahl, M. |
|
1998 |
34 |
5 |
p. 668-673 6 p. |
article |
26 |
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI
|
Pagani, O. |
|
1998 |
34 |
5 |
p. 632-640 9 p. |
article |
27 |
Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group
|
Keilholz, U |
|
1998 |
34 |
5 |
p. 750-753 4 p. |
article |
28 |
Skin melanoma in Italy: a population-based study on survival and prognostic factors
|
Balzi, D |
|
1998 |
34 |
5 |
p. 699-704 6 p. |
article |
29 |
The health status of adult survivors of cancer in childhood
|
Stevens, M.C.G |
|
1998 |
34 |
5 |
p. 694-698 5 p. |
article |
30 |
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy
|
Kuczyk, M.A. |
|
1998 |
34 |
5 |
p. 679-686 8 p. |
article |
31 |
Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971–1995
|
Post, P.N |
|
1998 |
34 |
5 |
p. 705-709 5 p. |
article |